Dimitrije Damjanov

Dr. Dimitrije Damjanov

Department of Internal Medicine, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
NKNadica Dimitrije Kovačević
Nadica Dimitrije Kovačević
VPvedrana petric
vedrana petric
MPMaria Pete
Maria Pete
MPMilica Popović
Milica Popović
AĐAleksandra Plećaš Đuric
Aleksandra Plećaš Đuric
MLMilica Lekin
Milica Lekin
The aim of this study was to investigate the differences of Clostridioides difficile infection (CDI) during the COVID-19 pandemic compared to the pre-COVID-19 era. CDI patients treated at the Clinic for Infectious Diseases, Clinical Center of Vojvodina, Serbia during 2017–2019 (n = 304) were compared with COVID-19/CDI patients treated in period September 2021–September 2022 (n = 387). Groups were compared by age, gender, comorbidities, previous medications, laboratory findings, and outcome within 30 days. In the CDI/COVID-19 group, we found: greater percentage of males 59.8% vs. 42.6% (p ≤ 0.001), older age 72.8 ± 9.4 vs. 65.6 ± 11.7 (p ≤ 0.001), higher Charlson comorbidity score (CCS) (3.06 ± 1.54 vs. 2.33 ± 1.34 (p ≤ 0.001), greater percentage of chronic renal failure (33.9% vs. 23.4% (p = 0.003), malignances (24.3% vs. 13.5% (p ≤ 0.001), chronic obstructive pulmonary disease (22.7% vs. 15.5% (p = 0.017), higher usage of macrolide (38.5% vs. 8.6% (p ≤ 0.001), greater percentage of patients with hypoalbuminemia ≤25 g/L (19.6% vs. 12.2% (p ≤ 0.001), lower percentage of patients with elevated creatinine (≥200 mmol/L) (31.5% vs. 43.8%) (p = 0.002), and greater percentage of lethal outcome 29.5% vs. 6.6% (p ≤ 0.001). In the prediction of lethal outcome multivariate regression analysis extracted as an independent predictor, only higher CRP values in the non-COVID-19 group and in the COVID-19 group: older age (p ≤ 0.001), CCS (p = 0.019) and CRP (p = 0.015). COVID-19 changes the disease course of CDI and should be taken into consideration when managing those patients.

12 September 2022 in Medicina
Verified
Journal Article
Open access
PDF file
NKNadica Dimitrije Kovačević
Nadica Dimitrije Kovačević
DLDajana Lendak
Dajana Lendak
MPMilica Popović
Milica Popović
AĐAleksandra Plećaš Đuric
Aleksandra Plećaš Đuric
MPMaria Pete
Maria Pete
MLMilica Lekin
Milica Lekin
Background: This study aimed to investigate the clinical form, risk factors, and outcomes of patients with COVID-19 and Clostridioides difficile co-infections. Methods: This retrospective study (2 September 2021–1 April 2022) included all patients with Clostridioides difficile infection (CDI) and COVID-19 infection who were admitted to the Covid Hospital of the University Clinical Center of Vojvodina. Results: A total of 5124 COVID-19 patients were admitted to the Covid Hospital, and 326 of them (6.36%) developed hospital-onset CDI. Of those, 326 of the CDI patients (88.65%) were older than 65 years. The median time of CDI onset was 12.88 days. Previous hospitalizations showed 69.93% of CDI patients compared to 38.81% in the non-CDI group (p = 0.029). The concomitant antibiotics exposure was higher among the CDI group versus the non-CDI group (88.65% vs. 68.42%, p = 0.037). Albumin levels were ≤ 25 g/L among 39.57% of the CDI patients and 21.71% in the non-CDI patients (p = 0.021). The clinical manifestations of CDI ranged from mild diarrhea (26.9%) to severe diarrhea (63.49%) and a complicated form of colitis (9.81%). Regarding outcomes, 79.14% of the CDI patients recovered and 20.86% had fatal outcomes in-hospital. Although a minority of the patients were in the non-CDI group, the difference in mortality rate between the CDI and non-CDI group was not statistically significant (20.86% vs. 15.13%, p = 0.097). Conclusions: Elderly patients on concomitant antibiotic treatments with hypoalbuminemia and with previous healthcare exposures were the most affected by COVID-19 and CD co-infections.

22 September 2024 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
Dimitrije DamjanovDimitrije Damjanov
Dimitrije Damjanov
TITijana Ičin
Tijana Ičin
ZSZeljka Savic
Zeljka Savic
NJNebojša Janjić
Nebojša Janjić
SNStanislava Nikolic
Stanislava Nikolic
NKNadica Dimitrije Kovačević
Nadica Dimitrije Kovačević
Background/Objectives: Most cases of colorectal cancer (CRC) arise from adenomatous polyps. Identifying risk factors for colorectal adenoma (CRA) is critical for CRC prevention. Emerging evidence suggests a link between metabolic syndrome (MetS) and an elevated risk of CRA and CRC, potentially mediated by visceral obesity and adiponectin (APN). We aimed to evaluate the association between different markers of visceral obesity, serum APN, MetS, and the presence of CRA. Methods: A cross-sectional study was conducted at the University Clinical Center of Vojvodina, involving 120 patients, aged 40–75 years, who underwent colonoscopy between January 2022 and January 2023. Sixty patients with CRA were compared to 60 controls with normal colonoscopy findings. Visceral fat thickness (VFT) was measured using ultrasound (US), and bioelectrical impedance analysis (BIA) was used to assess visceral fat area (VFA). Serum APN levels, anthropometric measures, and MetS components were also evaluated. Results: Patients with CRA had significantly higher VFT measured by US (p < 0.05), but no significant differences were found in VFA measured by BIA, waist circumference (WC), or waist-to-hip ratio (WHR). MetS was significantly more prevalent in the CRA group (55% vs. 31.6%, p < 0.05), and logistic regression confirmed MetS as a significant predictor of CRA presence (OR = 2.6). Serum APN levels were inversely correlated with visceral fat measurements and MetS (p < 0.01), but no significant difference in APN levels was observed between patients with and without CRA. Conclusions: This study highlights the importance of VFT measured by US and the presence of MetS as significant factors associated with CRA.

1 January 2022 in Vojnosanitetski Pregled
Verified
Journal Article
Open access
PDF file
ZKZarko Krnetic
Zarko Krnetic
TPTatjana Pesic
Tatjana Pesic
ZSZeljka Savic
Zeljka Savic
TJTatiana Jocic
Tatiana Jocic
OLOlgica Latinovic-Bosnjak
Olgica Latinovic-Bosnjak
Dimitrije DamjanovDimitrije Damjanov
Dimitrije Damjanov
Introduction. Among the acute hepatic porphyrias, a small percentage of patients, predominantly female, present with recurrent cyclic attacks of acute intermittent porphyria that occur more than three times a year and sometimes at intervals of less than a month. In women, the attacks are typically related to the menstrual cycle, requiring several days of hospitalization and administration of heme arginate. For these patients, prophylactic heme arginate therapy may be the optimal treatment modality. Case report. We presented a 40-year-old female patient who has been suffering from porphyria for seventeen years. The first attack occurred in 2003, presenting with severe neurological symptoms, requiring the use of heme arginate (Normosang((R)), Orphan Europe), which resulted in a favorable therapeutic response. In 2004 and 2007, gonadorelin analogue goserelin (Zoladex((R))) was used, but without beneficial effects on the course of the disease. In 2008, a preventive administration of heme arginate was initiated. The patient received heme arginate in the early phase of symptoms, every month in the premenstrual phase of the cycle, which resulted in milder symptoms, full recovery within 24 hours, lower doses of Normosang((R)) (1-2 ampoules), and fewer hospital days (1-2 days) per month. This regimen has significantly improved the patient's quality of life and reduced the risk of potential adverse effects. Conclusion. Preventive use of Normosang((R)) is the optimal therapeutic modality in patients with frequent, recurrent severe attacks that are unresponsive to other therapeutic regimens. As a result, patients have a better quality of life due to an effective, short-term, targeted treatment regimen.

1 January 2019 in Vojnosanitetski Pregled
Verified
Journal Article
Open access
PDF file
Dimitrije DamjanovDimitrije Damjanov
Dimitrije Damjanov
TJTatiana Jocic
Tatiana Jocic
OLOlgica Latinovic-Bosnjak
Olgica Latinovic-Bosnjak
DDDragomir Damjanov
Dragomir Damjanov
ZSZeljka Savic
Zeljka Savic
ZKZarko Krnetic
Zarko Krnetic
Introduction. Syphilis rarely affects anorectal region. The symptoms are nonspecific and are commonly disregarded in our country. Therefore, they pose a difficulty both for a diagnosis and for a treatment.We presented a patient with the clinical, laboratory, endoscopic and histological characteristics of rectal siphilis who was initially suspected to have inflammatory bowel disease. Case report. A 29-year-old man was hospitalized with a suspected inflammatory bowel disease, with symptoms such as frequent blood-stained diarrhea, lower abdominal pain and a loss of appetite. The physical examination showed maculopapular skin rash on the body. The ileocolonoscopic examination revealed finely granulated rectal mucosa, the loss of vascular pattern, and at 3 cm from the anal verge, an exulcerated submucosal lesion 1.2 cm in diameter, with two smaller, similar looking lesions. The histological examination of biopsies showed diffuse inflammatory-cell infiltration, with cryptitis, Paneth cell metaplasia with granuloma without caseous necrosis, which was highly suggestive of Crohn?s disease. The Treponema pallidum test results were positive [hemagglutination assay (TPHA)] with a titer 1 : 2,560 and the rapid plasma reagin test (RPR) with a titer 1 : 16. The ensuing detailed anamnesis on the patient?s sexual behavior showed that the patient had unprotected anal sexual relation with another man and the diagnosis of secondary syphilis was confirmed. After the treatment with benzathine penicillin G once a week, during a three-week period, the patient had no symptoms and had normal inflammatory markers, with a significant decrease of RPR titre and normal mucosa on rectosigmoidoscopy. Conclusion. Taking in consideration the variable clinical and endoscopic manifestations of this disease, it is necessary to take a detailed history of sexual behavior, since it can be crucial for determining the diagnosis and differential diagnosis of syphilis.

1 January 2025 in Vojnosanitetski Pregled
Verified
Journal Article
Open access
PDF file
Dimitrije DamjanovDimitrije Damjanov
Dimitrije Damjanov
ZSZeljka Savic
Zeljka Savic
OLOlgica Latinovic-Bosnjak
Olgica Latinovic-Bosnjak
ZKZarko Krnetic
Zarko Krnetic
VVVladimir Vracaric
Vladimir Vracaric
BDBožidar Dejanović
Božidar Dejanović
Background/Aim. Metabolic syndrome (MetS) is associated with an increased risk of developing colorectal cancer (CRC). However, data on its relationship with colorectal adenomas (CRA), the primary precancerous lesions, remain unclear and limited in certain regions. The aim of this study was to examine the characteristics and distribution of CRA in patients with and without MetS. Methods. A cross-sectional study was conducted, including 80 patients with CRA, of whom 40 had MetS (MetS group), and 40 did not meet the criteria for MetS (control group). Demographic data, risk factors for CRC (smoking, alcohol consumption, and family history of CRC), protective factors (use of acetylsalicylic acid and nonsteroidal anti-inflammatory drugs, physical activity), and polyp characteristics (size, number, localization, and degree of advancement) were collected and compared between the two groups. The diagnosis of CRA was established by histological examination of polyp specimens retrieved during colonoscopy. The diagnosis of MetS was made if three or more of the following criteria were present: increased waist circumference (? 94 cm for males, or ? 8 0 c m f or f emales); hypertriglyceridemia (? 1.7 mmol/L); reduced high-density lipoprotein cholesterol levels (< 1.0 mmol/L for males, or < 1.3 mmol/L for females); arterial hypertension (systolic blood pressure ? 130 mmHg, and/or diastolic blood pressure ? 85 mmHg); fasting hyperglycaemia (? 5.6 mmol/L). Results. The average age of the patients was 61 years. Males and females were equally present in both groups, as were all the common risk factors for CRA. There were no differences between the groups regarding adenoma size, number of detected adenomas, localization of adenomas, and the degree of histological advancement of the adenoma. Conclusion. No significant association was found between the presence of MetS and the characteristics and distribution of CRA in our study. Further studies with larger samples and biomarker analyses are needed to better understand the potential role of MetS-related factors in colorectal carcinogenesis.